Longitudinal Follow-Up of Serum and Urine Biomarkers Indicative of COVID-19-Associated Acute Kidney Injury: Diagnostic and Prognostic Impacts

被引:2
|
作者
Lablad, Yahya [1 ]
Vanhomwegen, Charlotte [1 ]
De Prez, Eric [1 ]
Antoine, Marie-Helene [1 ]
Hasan, Sania [1 ]
Baudoux, Thomas [1 ,2 ]
Nortier, Joelle [1 ]
机构
[1] Univ Libre Bruxelles, Fac Med, Lab Expt Nephrol, Erasme Campus,808 Route Lennik, B-1070 Brussels, Belgium
[2] Erasme Univ Hosp, Dept Nephrol Dialysis & Renal Transplantat, Erasme Campus, B-1070 Brussels, Belgium
关键词
AKI; COVID-19; biomarkers; NGAL; LAP; CCL14; cystatin C; suPAR; SOLUBLE UROKINASE RECEPTOR; COVID-19; PATIENTS;
D O I
10.3390/ijms242216495
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In patients hospitalized for severe COVID-19, the incidence of acute kidney injury (AKI) is approximately 40%. To predict and understand the implications of this complication, various blood and urine biomarkers have been proposed, including neutrophil gelatinase-associated lipocalin (NGAL), chemokine (C-C motif) ligand 14 (CCL14), cystatin C, leucine aminopeptidase (LAP), and soluble urokinase plasminogen activator (suPAR). This study, conducted between mid-January and early May 2021, aimed to assess the diagnostic and prognostic capabilities of these biomarkers in a cohort of COVID-19 patients monitored during the initial two weeks of hospitalization. Among the 116 patients included in this study, 48 developed AKI within the first three days of hospitalization (41%), with 29 requiring intensive care unit (ICU) admission, and the overall mortality rate was 18%. AKI patients exhibited a statistically significant increase in urinary LAP levels, indicating acute tubular injury as a potential mechanism underlying COVID-19-related renal damage. Conversely, urinary NGAL and CCL-14 excretion rates did not differ significantly between the AKI and non-AKI groups. Importantly, elevated plasma suPAR and cystatin C levels upon admission persisted throughout the first week of hospitalization and were associated with unfavorable outcomes, such as prolonged ICU stays and increased mortality, irrespective of AKI development. In conclusion, this study underscores the early predictive value of urinary LAP levels in identifying acute tubular injury in COVID-19-induced AKI. Moreover, elevated plasma suPAR and cystatin C levels serve as valuable prognostic markers, offering insights into the short-term morbidity and mortality risks among COVID-19 patients, regardless of AKI occurrence. These findings shed light on the complex interplay between COVID-19, renal injury, and biomarkers with diagnostic and prognostic potential.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] One Year's Observational Study of Acute Kidney Injury Incidence in Primary Care; Frequency of Follow-Up Serum Creatinine and Mortality Risk
    Barton, Anna L.
    Mallard, Angela S.
    Parry, Rob G.
    NEPHRON, 2015, 130 (03) : 175 - 181
  • [42] Potential protective effects of Huanglian Jiedu Decoction against COVID-19-associated acute kidney injury: A network-based pharmacological and molecular docking study
    Wu, Weichu
    Zhang, Yonghai
    Liu, Guoyuan
    Chi, Zepai
    Zhang, Aiping
    Miao, Shuying
    Lin, Chengchuang
    Xu, Qingchun
    Zhang, Yuanfeng
    OPEN MEDICINE, 2023, 18 (01):
  • [43] Meta-analysis of the diagnostic value of serum, plasma and urine neutrophil gelatinase-associated lipocalin for the detection of acute kidney injury in patients with sepsis
    Zhou, Hong
    Cui, Juan
    Lu, You
    Sun, Jing
    Liu, Jianzhou
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (04)
  • [44] Critically ill patients with COVID-19-associated acute kidney injury treated with kidney replacement therapy: Comparison between the first and second pandemic waves in São Paulo, Brazil
    Samaan, Farid
    Freitas, Rafaela Andrade Penalva
    Viana, Renata
    Gambaro, Livia
    Cunha, Karlla
    Vieira, Tales Dantas
    Feitosa, Valkercyo
    Correa, Eric Aragao
    Maciel, Alexandre Toledo
    Aranha, Sylvia
    Osawa, Eduardo Atsushi
    Pillar, Roberta
    Flato, Elias Marcos da Silva
    da Silva, Renata Cristina
    Carneiro, Elisa
    Souza, Fabrizzio Batista Guimaraes de Lima
    Rossi, Paula Regina Gan
    Abud, Munira Bittencourt
    Konigsfeld, Henrique Pinheiro
    da Silva, Riberto Garcia
    de Souza, Ricardo Barbosa Cintra
    Coutinho, Saurus Mayer
    Goes, Miguel angelo
    da Silva, Barbara Antunes Bruno
    Zanetta, Dirce Maria Trevisan
    Burdmann, Emmanuel Almeida
    PLOS ONE, 2023, 18 (11):
  • [45] Severe Covid-19 and acute pulmonary hypertension: 24-month follow-up regarding mortality and relationship to initial echocardiographic findings and biomarkers
    Norderfeldt, Joakim
    Liliequist, Andreas
    Eksborg, Staffan
    Frostell, Claes
    Eriksson, Maria J.
    Adding, Christofer
    Agvald, Per
    Lonnqvist, Per-Arne
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2023, 67 (02) : 206 - 212
  • [46] Post-Acute COVID-19 Sequelae in a Working Population at One Year Follow-Up: A Wide Range of Impacts from an Italian Sample
    Buonsenso, Danilo
    Gualano, Maria Rosaria
    Rossi, Maria Francesca
    Gris, Angelica Valz
    Sisti, Leuconoe Grazia
    Borrelli, Ivan
    Santoro, Paolo Emilio
    Tumminello, Antonio
    Gentili, Carolina
    Malorni, Walter
    Valentini, Piero
    Ricciardi, Walter
    Moscato, Umberto
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (17)
  • [47] Exploring miR-577 and miR-494-3p as Emerging Biomarkers in Sepsis-Associated Acute Kidney Injury: Diagnostic and Prognostic Perspectives
    Xu, Lixia
    Li, Jingpo
    Li, Li
    Zhang, Qiushuang
    Feng, Qiuju
    Bai, Lijie
    MICROBIOLOGY AND IMMUNOLOGY, 2025, : 297 - 306
  • [48] Incidence of Serum Creatinine Monitoring and Outpatient Visit Follow-Up among Acute Kidney Injury Survivors after Discharge: A Population-Based Cohort Study
    Barreto, Erin F.
    Schreier, Diana J.
    May, Heather P.
    Mara, Kristin C.
    Chamberlain, Alanna M.
    Kashani, Kianoush B.
    Piche, Shannon L.
    Wi, Chung-Il
    Kane-Gill, Sandra L.
    Smith, Victoria T.
    Rule, Andrew D.
    AMERICAN JOURNAL OF NEPHROLOGY, 2021, 52 (10-11) : 817 - 826
  • [49] Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study
    Fumagalli, Carlo
    Zocchi, Chiara
    Tassetti, Luigi
    Silverii, Maria Vittoria
    Amato, Carla
    Livi, Luca
    Giovannoni, Lorenzo
    Verrillo, Federica
    Bartoloni, Alessandro
    Marcucci, Rossella
    Lavorini, Federico
    Fumagalli, Stefano
    Ungar, Andrea
    Olivotto, Iacopo
    Rasero, Laura
    Fattirolli, Francesco
    Marchionni, Niccolo
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 97 : 36 - 41
  • [50] Chronic fatigue syndrome and cognitive deficit are associated with acute-phase neuropsychiatric manifestations of COVID-19: A 9-month follow-up study
    Fatemeh Sadat Mirfazeli
    Atiye Sarabi-Jamab
    Victor Pereira-Sanchez
    Alireza Kordi
    Behnam Shariati
    Seyed Vahid Shariat
    Salar Bahrami
    Shabnam Nohesara
    Mostafa Almasi-Dooghaee
    Seyed Hamid Reza Faiz
    Neurological Sciences, 2022, 43 : 2231 - 2239